Epithalon (50mg)

$79

A tetrapeptide developed by Russian researcher Vladimir Khavinson and studied for its effects on telomerase activity. A 12-year study in elderly populations reported a 50% reduction in mortality rates over the observation window — among the most striking results in bioregulator research.

Category:

Description

What it is

A tetrapeptide developed by Russian researcher Vladimir Khavinson, studied for its effects on telomerase activity and pineal function. One of the most-researched bioregulators in longevity science.

Why it’s studied

Epithalon is one of the few research peptides with long-term human observational data — including a 12-year study tracking mortality outcomes in elderly populations.

Key research findings

  • ~50% reduction in mortality rates over 12 years (Khavinson et al., elderly population study)

  • Documented telomerase activation in human cell culture research

  • Effects on pineal melatonin regulation in animal models